Skip to content

Drug prices are too high. What is Congress trying to do about it?

Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)

Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.

But what would these various proposals accomplish, and how likely is it they’ll be signed into law?

[jwp-video n=”1″]

Recent Stories

Capitol Lens | Pipes of peace

Former House members reflect on 25th anniversary of Sept. 11 attacks

‘Tired of politics’: By GOP convention’s end, even Trump had tapped out

‘He’s not going away’: GOP loyalists not ready for Trump to leave political stage

Roll Call on the Road: Day Two in Dallas

Taxpayers spent more than $500,000 on House sexual harassment payouts